No evidence of disease activity-3 (NEDA-3) status in patients with relapsing remitting multiple sclerosis: Evidence from Saudi cohort receiving mainly Interferon.

Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): Azra Zafar, Foziah Jabbar Gossab AlShamrani
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research